Factors influencing the concentration of valproic acid in patients with diagnosed epilepsy

被引：0
|
作者：
Szczygiel-Pilut, E. [1 ,2 ]
机构：
[1] John Paul 2 Hosp, Dept Neurol, Substroke Unit, Krakow, Poland
[2] John Paul 2 Hosp, Subdept Neurol Rehabil, Krakow, Poland
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
774
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [41] RISK FACTORS FOR VALPROIC ACID NON-RESPONSE IN CHILDHOOD ABSENCE EPILEPSY
    Ollivier, May L.
    Dubois, Marie-France
    Cossette, P.
    Krajinovic, M.
    Carmant, Lionel
    EPILEPSIA, 2008, 49 : 91 - 92
  • [42] Ertapenem/valproic acid interactionSubtherapeutic valproic acid concentration: case report
    Reactions Weekly, 2017, 1646 (1) : 148 - 148
  • [43] Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy
    Jayalakshmi, Sita
    Vooturi, Sudhindra
    Bana, Ashok Kumar
    Sailaja, Sarva
    Somayajula, Shanmukhi
    Mohandas, Surath
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (07): : 527 - 532
  • [44] FACTORS INFLUENCING THE RELATIONSHIP BETWEEN CARBAMAZEPINE PLASMA-CONCENTRATION AND ITS CLINICAL EFFECTS IN PATIENTS WITH EPILEPSY
    RAPEPORT, WG
    CLINICAL NEUROPHARMACOLOGY, 1985, 8 (02) : 141 - 149
  • [45] Therapeutic Drug Monitoring of Lacosamide in Chinese Pediatric Patients with Epilepsy: Efficacy and Factors Influencing the Plasma Concentration
    Zhao, Ting
    Li, Hong-jian
    Zhang, Hui-lan
    Yu, Jing
    Feng, Jie
    Wang, Ting-ting
    Sun, Yan
    Yu, Lu-hai
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 41 - 49
  • [46] Therapeutic Drug Monitoring of Lacosamide in Chinese Pediatric Patients with Epilepsy: Efficacy and Factors Influencing the Plasma Concentration
    Ting Zhao
    Hong-jian Li
    Hui-lan Zhang
    Jing Yu
    Jie Feng
    Ting-ting Wang
    Yan Sun
    Lu-hai Yu
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 41 - 49
  • [47] Valproic Acid Serum Concentration and Incidence of Toxicity in Pediatric Patients
    Young, McKenzie R.
    Bisaccia, Elizabeth K.
    Romantseva, Lubov
    Hovey, Sara W.
    JOURNAL OF CHILD NEUROLOGY, 2022, 37 (06) : 461 - 470
  • [48] EVALUATION OF BINDING-EQUATION METHOD FOR PREDICTION OF UNBOUND SERUM VALPROIC ACID CONCENTRATION IN PEDIATRIC-PATIENTS WITH EPILEPSY
    KODAMA, Y
    KURANARI, M
    KODAMA, H
    KOIKE, Y
    YASUNAGA, F
    FUJII, I
    TAKEYAMA, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (02) : 114 - 118
  • [49] Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis (Publication with Expression of Concern)
    Nakashima, Hiroo
    Oniki, Kentaro
    Nishimura, Miki
    Ogusu, Naoki
    Shimomasuda, Masatsugu
    Ono, Tatsumasa
    Matsuda, Kazuki
    Yasui-Furukori, Norio
    Nakagawa, Kazuko
    Ishitsu, Takateru
    Saruwatari, Junji
    PLOS ONE, 2015, 10 (10):
  • [50] ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy
    Chen, Juan
    Su, Qi-Biao
    Tao, Yu-Qian
    Qin, Jia-Ming
    Zhou, Yi
    Zhou, Shan
    Li, Hong-Liang
    Chen, Zhuo-Jia
    Zhou, Ya-Fang
    Zhou, Lie-Min
    Wang, Xue-Ding
    Huang, Min
    PHARMAZIE, 2018, 73 (05): : 279 - 282
12345